5610 results
Refine Your Search
Estudio de la Sociedad de Lucha contra la Leucemia y el Linfoma muestra que las vacunas contra la COVID-19 son seguras, pero el 25% de los pacientes con cáncer de la sangre no producen niveles detectables de anticuerpos
Si eres un paciente o un sobreviviente de cancer de sangre, lea mas en nuestras preguntas frecuentes sobre la vacuna aqui. Referencias bibliográfic…
Oya
My three kids are my precious jewels, the reason I get up every morning. As a single parent, providing a good life for them is what fuels my drive to …
Living with Myeloma
The Leukemia & Lymphoma Society Nurse Navigators Help Patients Overcome Barriers to and Enroll in Blood Cancer Clinical Trials
Analysis of the LLS model supports the potential that it can be replicated to increase patient access to clinical trials across all cancer types
Other
FDA Approval: New Treatment Indication for Multiple Myeloma Drug
RYE BROOK, N.Y., August , - The U.S. Food and Drug Administration (FDA) today announced approval of daratumumab plus hyaluronidase (Darzalex Faspro®)…
News Release
Volunteer
It all began in after my friend Cara and I ran the LA Marathon. We had already trained on our own for the . miles race. I thought, “Why not just keep…
FDA Approves New Treatment Option For Chronic Graft-Versus-Host-Disease In Patients Ages 12 Years And Older
RYE BROOK, N.Y., August , - The U.S. Food and Drug Administration (FDA) recently approved belumosudil (Rezurock™) in patients years or older for the…
News Release
CDP Achievement Awards 2019
The winners of the 1st Annual CDP Achievement Awards were announced at the ASH Annual Meeting and the awards were presented at the LLS Career Develop…
CDP Achievement Awards 2020
Due to the global pandemic, the winners of the second annual CDP Achievement Awards received their awards via mail, but we are looking forward to con…
LLS CDP Achievement Awards
The Career Development Program (CDP) grants support researchers early and at different stages of their career: from those with less than two years of …
Dr. Ravi Majeti: 2020 CDP Achievement Award Winner
SCHOLAR ACHIEVEMENT AWARD Dr. Ravi Majeti is Professor of Medicine, Chief of the Division of Hematology, and Member of the Institute for Stem Ce…
Dr. Daniel Starczynowski: 2020 CDP Achievement Award Winner
SCHOLAR ACHIEVEMENT AWARD Dr. Daniel Starczynowski leads a laboratory at Cincinnati Children’s Hospital focused on the intersection of inflammat…
Update on Acute Lymphoblastic Leukemia
Topics Covered We invite you to learn more about: Current and emerging therapies for Acute Lymphoblastic Leukemia (ALL) Treatment side effects an…
CLL: Navigating Treatment with BTK Inhibitors
PresentationClick Here
Dr. Matthew Witkowski: 2020 CDP Achievement Award Winner
FELLOW ACHIEVEMENT AWARD Dr. Matthew Witkowski was awarded his PhD degree at the Walter and Eliza Hall Institute in Melbourne, Australia based on his…
Dr. Akihide Yoshimi: 2020 CDP Achievement Award Winner
FELLOW ACHIEVEMENT AWARD Dr. Yoshimi is a from the University of Tokyo who joined the lab as postdoctoral fellow and senior research scientist i…
ACA OPEN ENROLLMENT THROUGH MAY 15, 2021
Cancer patients have faced unique challenges in access to care, particularly during the pandemic. Cancer care can make these challenges more difficu…
A. Timothy
In , I was playing baseball in high school as a freshman, playing second base. A bully made a hit and ran from first to second base, tackling me. I go…
Celia
March , : The day my life changed forever. It was the Sunday before my third year of medical school started back up after spring break. It was also th…
FDA Approves New Treatment Option for Patients with Relapsed or Refractory Large B-Cell Lymphoma
RYE BROOK, N.Y., August , - The U.S. Food and Drug Administration (FDA) approved loncastuximab (ZYNLONTA) to treat adult patients with relapsed or r…
News Release